1. Home
  2. TELO vs INUV Comparison

TELO vs INUV Comparison

Compare TELO & INUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELO
  • INUV
  • Stock Information
  • Founded
  • TELO 2021
  • INUV N/A
  • Country
  • TELO United States
  • INUV United States
  • Employees
  • TELO N/A
  • INUV N/A
  • Industry
  • TELO
  • INUV Advertising
  • Sector
  • TELO
  • INUV Consumer Discretionary
  • Exchange
  • TELO NYSE
  • INUV Nasdaq
  • Market Cap
  • TELO 58.6M
  • INUV 62.8M
  • IPO Year
  • TELO 2024
  • INUV N/A
  • Fundamental
  • Price
  • TELO $1.53
  • INUV $4.50
  • Analyst Decision
  • TELO
  • INUV Strong Buy
  • Analyst Count
  • TELO 0
  • INUV 2
  • Target Price
  • TELO N/A
  • INUV $20.00
  • AVG Volume (30 Days)
  • TELO 408.8K
  • INUV 177.7K
  • Earning Date
  • TELO 08-12-2025
  • INUV 08-07-2025
  • Dividend Yield
  • TELO N/A
  • INUV N/A
  • EPS Growth
  • TELO N/A
  • INUV N/A
  • EPS
  • TELO N/A
  • INUV N/A
  • Revenue
  • TELO N/A
  • INUV $93,478,114.00
  • Revenue This Year
  • TELO N/A
  • INUV $28.36
  • Revenue Next Year
  • TELO N/A
  • INUV $12.18
  • P/E Ratio
  • TELO N/A
  • INUV N/A
  • Revenue Growth
  • TELO N/A
  • INUV 18.20
  • 52 Week Low
  • TELO $1.52
  • INUV $1.90
  • 52 Week High
  • TELO $8.40
  • INUV $7.90
  • Technical
  • Relative Strength Index (RSI)
  • TELO 29.64
  • INUV 55.24
  • Support Level
  • TELO $1.65
  • INUV $3.30
  • Resistance Level
  • TELO $1.81
  • INUV $4.54
  • Average True Range (ATR)
  • TELO 0.17
  • INUV 0.37
  • MACD
  • TELO -0.01
  • INUV 0.04
  • Stochastic Oscillator
  • TELO 1.03
  • INUV 66.88

About TELO TELOMIR PHARMACEUTICALS INC

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

About INUV Inuvo Inc.

Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

Share on Social Networks: